Page 4 - Indian Pharma Companies
India and smug mediocrity
Indian democracy is equating excellence with elitism
 "India and smug mediocrity")
Covid vaccination drive: India well prepared to store, distribute vaccines
India has about 29,000 cold chain points, 1.6 million shipper boxes, 76,000 cold chain equipment, 700 reefer vans and 55,000 cold chain handlers
 "Covid vaccination drive: India well prepared to store, distribute vaccines")
Bharat Biotech concludes recruitment for Covaxin's phase 3 study
Bharat Biotech has concluded the recruitment of volunteers for the phase III trials of its Covid vaccine, Covaxin, on Thursday after achieving the sample size it had promised to the ethics committee
 "Bharat Biotech concludes recruitment for Covaxin's phase 3 study")
Bharat Biotech: A journey that started with a scientist's return to India
First a scientist and then a businessman, founder chairman Krishna Ella quit his faculty position at the Medical University of South Carolina in Charleston, United States, in 1996 to return to India
 "Bharat Biotech: A journey that started with a scientist's return to India")
A jab at risk: Serum's quest to lead the world in Covid-19 vaccine race
It took a chance by ramping up capacity on vaccines when they were yet to be approved and is set to emerge a global winner
 "A jab at risk: Serum's quest to lead the world in Covid-19 vaccine race")
Our goal now is to provide it globally: Bharat Biotech on Covaxin approval
Bharat Biotech on Sunday said the approval for emergency use of its Covid-19 vaccine-- Covaxin-- is a giant leap for innovation and novel product development in India
 "Our goal now is to provide it globally: Bharat Biotech on Covaxin approval")
The story behind the rise of Serum Institute, world's vaccine factory
Today, SII sells about 1.5 billion vaccine doses every year to 170 countries and is the largest producer of vaccines globally by number of doses
 "The story behind the rise of Serum Institute, world's vaccine factory")
Zydus Cadila receives drug regulator's nod for NAFLD medicine in India
ZydusCadila said it has received approval from the Drug Controller General of India (DCGI) for Saroglitazar Mg, used for the treatment of non-alcoholic fatty liver disease (NAFLD), in the country
 "Zydus Cadila receives drug regulator's nod for NAFLD medicine in India")
Health Minister inaugurates India's first pneumococcal conjugate vaccine
Union Health Minister Dr Harsh Vardhan On Monday inaugurated India's first pneumococcal conjugate vaccine "Pneumosil", which has been developed by the Serum Institute of India
 "Health Minister inaugurates India's first pneumococcal conjugate vaccine")
We are researching two candidates for Covid vaccines: Serum Institute CEO
In an e-mail interview with Sohini Das, Adar Poonawalla, chief executive officer, Serum Institute of India, says the firm is not raising additional capital through private equity
 "We are researching two candidates for Covid vaccines: Serum Institute CEO")
Pharma revenue, margins likely to remain healthy in next fiscal: ICRA
Revenue growth for IPM (Indian Pharmaceutical Market) is expected to be 7-9 per cent in FY2021 despite muted growth in Q1 FY2021
 "Pharma revenue, margins likely to remain healthy in next fiscal: ICRA")
Vial, syringe makers push the pedal as Covid-19 vaccine roll-out nears
Most firms plan to increase capacity to meet fresh orders
 "Vial, syringe makers push the pedal as Covid-19 vaccine roll-out nears")
Shelf life of vaccines likely to be more than 3 months, unlike drugs
They have the stability data for these investigational products, said a source
 "Shelf life of vaccines likely to be more than 3 months, unlike drugs")
India's first mRNA Covid-19 vaccine gets nod to start phase 1 trials
The Central Drugs Standard Control Organisation permitted Pune-based Gennova Biopharmaceuticals to conduct Phase 1/2 clinical trials for its mRNA Covid-19 vaccine candidate
 "India's first mRNA Covid-19 vaccine gets nod to start phase 1 trials")
The next online tonic: E-majors, corporate giants eye e-pharmacy business
Amazon, Reliance recently announced their foray into e-pharma sector
 "The next online tonic: E-majors, corporate giants eye e-pharmacy business")
Aurobindo Pharma completes sale of US subsidiary's Natrol to New Mountain
Drug firm Aurobindo Pharma said it has completed the sale of Natrol LLC, a wholly-owned unit of its US-based subsidiary, to private equity firm New Mountain Capital
 "Aurobindo Pharma completes sale of US subsidiary's Natrol to New Mountain")
Aurobindo Pharma expects to commercialise Covid-19 vaccine facility by May
Aurobindo Pharma expects to commercialise its Covid-19 vaccine manufacturing facility in Hyderabad by April-May next year, according to a top company official
 "Aurobindo Pharma expects to commercialise Covid-19 vaccine facility by May")
Indian pharma has bounced back from lockdown lows. What led to turnaround?
From the lows of the lockdown, the industry has seen a robust bounceback
 "Indian pharma has bounced back from lockdown lows. What led to turnaround?")
Serum Institute, Bharat Biotech gear up to export Covid-19 vaccine shots
Serum, Bharat Biotech in talks with countries, agencies to supply vaccines
 "Serum Institute, Bharat Biotech gear up to export Covid-19 vaccine shots")
Biological E's Covid-19 vaccine enters Phase I/II trial after DGCI nod
The results of this clinical trial are expected to be available by February 2021, the release said.
 "Biological E's Covid-19 vaccine enters Phase I/II trial after DGCI nod")
